Rothenberg, Michael E.
Tagen, Michael
Chang, Jae H.
Boyce-Rustay, Janel
Friesenhahn, Michel
Hackos, David H.
Hains, Avis
Sutherlin, Dan
Ward, Michael
Cho, William
Funding for this research was provided by:
Genentech
Article History
First Online: 6 June 2019
Change Date: 23 July 2019
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40261-019-00832-2
Compliance with Ethical Standards
:
: Michael E. Rothenberg, Michael Tagen, Jae H. Chang, Janel Boyce-Rustay, Michel Friesenhahn, David H. Hackos, Avis Hains, Dan Sutherlin, Michael Ward, and William Cho were employees of Genentech, Inc., a member of the Roche group, at the time this study was performed, and owned Roche stock and/or options at the time of their employment. Michael Tagen is currently an independent scientific consultant. Michael Ward is currently an employee of Alector, Inc., South San Francisco, CA, USA.
: This study was funded by Genentech, Inc.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the site’s Institutional Review Board.
: Informed consent was obtained from all individual participants included in the study.